Key result
TNF inhibitors carry serious infection and malignancy risks that require careful screening and monitoring.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.
No takes yet. Share an insight, caveat, or question.
Hadam et al. (2014) studied this question. TNF inhibitors pose infrequent but significant risks of serious infection and malignancy that can be minimized through patient selection, screening, and careful monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: